MENU
+Compare
PHGE
Stock ticker: ASE
AS OF
Apr 2 closing price
Price
$0.63
Change
+$0.14 (+28.57%)
Capitalization
15.72M

PHGE BiomX Inc Forecast, Technical & Fundamental Analysis

BiomX Inc is a clinical-stage microbiome company based in Israel... Show more

PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for PHGE with price predictions
Apr 02, 2025

PHGE's Indicator enters downward trend

The Aroon Indicator for PHGE entered a downward trend on April 02, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 247 similar instances where the Aroon Indicator formed such a pattern. In of the 247 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

PHGE moved below its 50-day moving average on February 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PHGE crossed bearishly below the 50-day moving average on March 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PHGE's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where PHGE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 02, 2025. You may want to consider a long position or call options on PHGE as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PHGE just turned positive on April 02, 2025. Looking at past instances where PHGE's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PHGE advanced for three days, in of 219 cases, the price rose further within the following month. The odds of a continued upward trend are .

PHGE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PHGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.857) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PHGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PHGE is expected to report earnings to fall 233.29% to -9 cents per share on November 13

BiomX Inc PHGE Stock Earnings Reports
Q3'24
Est.
$-0.09
Q2'24
Beat
by $0.16
Q1'24
Beat
by $0.35
Q4'23
Missed
by $0.42
Q3'23
Missed
by $0.03
The last earnings report on August 15 showed earnings per share of 7 cents, beating the estimate of -9 cents. With 1.42M shares outstanding, the current market capitalization sits at 15.72M.
A.I. Advisor
published General Information

General Information

a company, which engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
22 Einstein Street
Phone
+972 723942377
Employees
71
Web
https://www.biomx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVDA2.590.25
+10.68%
Iveda Solutions Inc
DKNG34.431.24
+3.74%
DraftKings
PLX2.590.05
+1.97%
Protalix BioTherapeutics
CYRX6.160.07
+1.15%
CryoPort
IRT21.380.02
+0.09%
Independence Realty Trust

PHGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHGE has been loosely correlated with APM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PHGE jumps, then APM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHGE
1D Price
Change %
PHGE100%
+27.59%
APM - PHGE
60%
Loosely correlated
+2.27%
HOFBF - PHGE
35%
Loosely correlated
N/A
BDRX - PHGE
27%
Poorly correlated
+28.33%
NRIX - PHGE
27%
Poorly correlated
+8.69%
AVTX - PHGE
26%
Poorly correlated
+3.36%
More